MAVENIR
27.2.2024 10:50:33 CET | Business Wire | Press release
solutions by stc, the leading enabler of digital transformation in Saudi Arabia and the region, announces an Open RAN agreement with Mavenir, the cloud-native network infrastructure provider building the future of networks, to launch the first commercial Open RAN network in Saudi Arabia. The announcement is a boost to stc’s Group strategic mission to deliver emerging technology to the Kingdom’s mobile customers, supporting the Vision 2030 digital transformation strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226664170/en/
Signing ceremony at Mobile World Congress (MWC) on stc stand in Hall 3. Executive company representatives: Yousef Almarshad, Chief Commercial Officer at solutions by stc & Pardeep Kohli, Chief Executive Office at Mavenir. (Photo: Business Wire)
The service is expected to go-live commercially with its next-generation Open RAN network in 2024, this decision follows a successful initial deployment for multi-layer 4G and 5G NSA Access Network on the Open RAN platform to stc, delivered in partnership with solutions by stc and Mavenir.
The newly launched multi-layered 4G and 5G Radio network will utilize Mavenir’s 4G Remote Radio Unit (RRU) and 5G Massive MIMO (mMIMO) Active Antenna Unit (AAU) technology and leverage the cloud-native Mavenir Webscale Platform (MWP) with fully containerized Centralized Unit (CU) and Distributed Unit (DU) software. The solution will run on x86 commercial-off-the-shelf (COTS) hardware platform that represents best-in-class technology for open interface radio systems. Mavenir and Saudi Arabia-based partner solutions by stc will provide stc with a cloud-native deployment solution that harnesses a full combination of expert professional services plus cutting-edge hardware and software and seamlessly integrated into stc’s radio network.
Yousef Almarshad, Chief Commercial Officer of solutions by stc commented: “Mavenir’s Open RAN technology innovation, together with solutions by stc unrivalled experience in the Saudia Arabia market, provide a strong foundation for this trail-blazing Open RAN deployment, bringing the next-generation performance and breakthrough services to stc’s valued customers across the Kingdom – going beyond data speeds to a more sustainably, securely and cost-effective network powered by Mavenir’s Open RAN.”
BG Kumar, President, Access Networks, Platforms and Digital Enablement at Mavenir, added: “Mavenir is extremely pleased to be awarded with the opportunity to build the first commercial Open RAN deployment in Saudi Arabia in collaboration with solutions by stc. Mavenir is confident that stc’s Open RAN network in Saudi Arabia will act as a catalyst for further accelerating operators’ digital transformation journeys across the Middle East region, ushering in a wave of customer-focused innovation that can fully leverage the unique potential generated by open standards and architecture.”
About stc Group:
stc group is an engine of digital transformation in the region, offering advanced solutions and driving the digitisation process. The group offers landline and fixed infrastructure, mobile and data services, and broadband & cloud computing services. www.stc.com.sa
About solutions by stc:
solutions by stc represents the driving force of digital transformation in the Kingdom of Saudi Arabia and the region, and the number one provider of information technology solutions in Saudi.
solutions aims to empower the public and private sectors by meeting the requirements of the digital age and adopting its latest trends. It also works to provide its customers with a diverse portfolio of services and products to support their daily operations, as the basic communications and information technology services provided by the company are designed to enable management and expansion of business.
solutions by stc started its operations more than 25 years ago and has provided its services to nearly 24,000 clients in 35 cities in Saudi Arabia and the region. The company's experience spans across several key sectors, including banking, healthcare, education, oil and gas, real estate, and telecom. The company has approximately 1,700 employees, including more than 1,000 with certifications in core technology areas. www.solutions.com.sa
About Mavenir:
Mavenir is building the future of networks today with cloud-native, AI-enabled solutions which are green by design, empowering operators to realize the benefits of 5G and achieve intelligent, automated, programmable networks. As the pioneer of Open RAN and a proven industry disruptor, Mavenir’s award-winning solutions are delivering automation and monetization across mobile networks globally, accelerating software network transformation for 300+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. For more information, please visit www.mavenir.com
Meet Mavenir at Mobile World Congress 2024 (Barcelona, Feb 26 – 29 2024)
To explore our latest innovations, MWC show announcements and learn more about how Mavenir is delivering the Future of Networks – Today, visit our team in Hall 2 (Stand 2H60).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226664170/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release
Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom